Published in Genes Dev on August 01, 1993
Identification and cloning of unc-119, a gene expressed in the Caenorhabditis elegans nervous system. Genetics (1995) 5.33
Genes critical for muscle development and function in Caenorhabditis elegans identified through lethal mutations. J Cell Biol (1994) 3.25
Heparan sulfate proteoglycans. Cold Spring Harb Perspect Biol (2011) 2.96
Perlecan maintains the integrity of cartilage and some basement membranes. J Cell Biol (1999) 2.94
Functional genomic analysis of C. elegans molting. PLoS Biol (2005) 2.39
Assembly of body wall muscle and muscle cell attachment structures in Caenorhabditis elegans. J Cell Biol (1994) 2.26
A conserved LIM protein that affects muscular adherens junction integrity and mechanosensory function in Caenorhabditis elegans. J Cell Biol (1999) 2.17
The UNC-112 gene in Caenorhabditis elegans encodes a novel component of cell-matrix adhesion structures required for integrin localization in the muscle cell membrane. J Cell Biol (2000) 2.06
Peroxidasin: a novel enzyme-matrix protein of Drosophila development. EMBO J (1994) 1.95
The biology of perlecan: the multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices. Biochem J (1994) 1.87
The Caenorhabditis elegans gene unc-89, required fpr muscle M-line assembly, encodes a giant modular protein composed of Ig and signal transduction domains. J Cell Biol (1996) 1.77
An integrated strategy to study muscle development and myofilament structure in Caenorhabditis elegans. PLoS Genet (2009) 1.50
Alpha spectrin is essential for morphogenesis and body wall muscle formation in Caenorhabditis elegans. J Cell Biol (2002) 1.50
Acetylcholinesterase clustering at the neuromuscular junction involves perlecan and dystroglycan. J Cell Biol (1999) 1.50
Sarcomeres Pattern Proprioceptive Sensory Dendritic Endings through UNC-52/Perlecan in C. elegans. Dev Cell (2015) 1.49
Caenorhabditis elegans UNC-96 is a new component of M-lines that interacts with UNC-98 and paramyosin and is required in adult muscle for assembly and/or maintenance of thick filaments. Mol Biol Cell (2006) 1.39
Behavioral deficits during early stages of aging in Caenorhabditis elegans result from locomotory deficits possibly linked to muscle frailty. J Gerontol A Biol Sci Med Sci (2004) 1.35
The NC1/endostatin domain of Caenorhabditis elegans type XVIII collagen affects cell migration and axon guidance. J Cell Biol (2001) 1.34
Caenorhabditis elegans UNC-98, a C2H2 Zn finger protein, is a novel partner of UNC-97/PINCH in muscle adhesion complexes. Mol Biol Cell (2003) 1.33
Developmental genetic analysis of troponin T mutations in striated and nonstriated muscle cells of Caenorhabditis elegans. J Cell Biol (1996) 1.30
Myotactin, a novel hypodermal protein involved in muscle-cell adhesion in Caenorhabditis elegans. J Cell Biol (1999) 1.30
Computational rules for chemotaxis in the nematode C. elegans. J Comput Neurosci (1999) 1.22
The SEA module: a new extracellular domain associated with O-glycosylation. Protein Sci (1995) 1.20
The LIM domain protein UNC-95 is required for the assembly of muscle attachment structures and is regulated by the RING finger protein RNF-5 in C. elegans. J Cell Biol (2004) 1.14
Structural characterization of the complete human perlecan gene and its promoter. Proc Natl Acad Sci U S A (1993) 1.14
Complex patterns of alternative splicing mediate the spatial and temporal distribution of perlecan/UNC-52 in Caenorhabditis elegans. Mol Biol Cell (1999) 1.13
Extracellular sugar modifications provide instructive and cell-specific information for axon-guidance choices. Curr Biol (2008) 1.12
Perlecan and tumor angiogenesis. J Histochem Cytochem (2003) 1.09
Heparan 2-O-sulfotransferase, hst-2, is essential for normal cell migration in Caenorhabditis elegans. Proc Natl Acad Sci U S A (2005) 1.09
The C. elegans F-spondin family protein SPON-1 maintains cell adhesion in neural and non-neural tissues. Development (2008) 1.03
Life without perlecan has its problems. J Cell Biol (1999) 1.02
SMU-2 and SMU-1, Caenorhabditis elegans homologs of mammalian spliceosome-associated proteins RED and fSAP57, work together to affect splice site choice. Mol Cell Biol (2004) 1.02
Perlecan regulates developmental angiogenesis by modulating the VEGF-VEGFR2 axis. Matrix Biol (2009) 1.01
Molecular characterisation of transport mechanisms at the developing mouse blood-CSF interface: a transcriptome approach. PLoS One (2012) 1.00
Analysis of smu-1, a gene that regulates the alternative splicing of unc-52 pre-mRNA in Caenorhabditis elegans. Mol Cell Biol (2001) 1.00
Molecular structure of sarcomere-to-membrane attachment at M-Lines in C. elegans muscle. J Biomed Biotechnol (2010) 1.00
Border patrol: insights into the unique role of perlecan/heparan sulfate proteoglycan 2 at cell and tissue borders. Matrix Biol (2013) 0.99
Nidogen is nonessential and not required for normal type IV collagen localization in Caenorhabditis elegans. Mol Biol Cell (2000) 0.99
MUP-4 is a novel transmembrane protein with functions in epithelial cell adhesion in Caenorhabditis elegans. J Cell Biol (2001) 0.98
Role of perlecan in skeletal development and diseases. Glycoconj J (2003) 0.96
The Drosophila Perlecan gene trol regulates multiple signaling pathways in different developmental contexts. BMC Dev Biol (2007) 0.96
DIM-1, a novel immunoglobulin superfamily protein in Caenorhabditis elegans, is necessary for maintaining bodywall muscle integrity. Genetics (2003) 0.96
Genetic redundancy masks diverse functions of the tumor suppressor gene PTEN during C. elegans development. Genes Dev (2006) 0.93
Calpains mediate integrin attachment complex maintenance of adult muscle in Caenorhabditis elegans. PLoS Genet (2012) 0.90
FBN-1, a fibrillin-related protein, is required for resistance of the epidermis to mechanical deformation during C. elegans embryogenesis. Elife (2015) 0.90
C. elegans ten-1 is synthetic lethal with mutations in cytoskeleton regulators, and enhances many axon guidance defective mutants. BMC Dev Biol (2010) 0.89
The identities of sym-2, sym-3 and sym-4, three genes that are synthetically lethal with mec-8 in Caenorhabditis elegans. Genetics (2004) 0.89
Extracellular matrix regulates UNC-6 (netrin) axon guidance by controlling the direction of intracellular UNC-40 (DCC) outgrowth activity. PLoS One (2014) 0.88
Structural components of the nonstriated contractile apparatuses in the Caenorhabditis elegans gonadal myoepithelial sheath and their essential roles for ovulation. Dev Dyn (2007) 0.88
Mutations in the Caenorhabditis elegans U2AF large subunit UAF-1 alter the choice of a 3' splice site in vivo. PLoS Genet (2009) 0.87
C. elegans agrin is expressed in pharynx, IL1 neurons and distal tip cells and does not genetically interact with genes involved in synaptogenesis or muscle function. PLoS One (2007) 0.87
CD44 isoform expression follows two alternative splicing pathways in breast tissue. Am J Pathol (1998) 0.86
The mup-4 locus in Caenorhabditis elegans is essential for hypodermal integrity, organismal morphogenesis and embryonic body wall muscle position. Genetics (1997) 0.85
A decline in transcript abundance for Heterodera glycines homologs of Caenorhabditis elegans uncoordinated genes accompanies its sedentary parasitic phase. BMC Dev Biol (2007) 0.84
SAX-3 (Robo) and UNC-40 (DCC) regulate a directional bias for axon guidance in response to multiple extracellular cues. PLoS One (2014) 0.83
Genetics of extracellular matrix remodeling during organ growth using the Caenorhabditis elegans pharynx model. Genetics (2010) 0.82
Endostatin and endorepellin: A common route of action for similar angiostatic cancer avengers. Adv Drug Deliv Rev (2015) 0.82
Complex cooperative functions of heparan sulfate proteoglycans shape nervous system development in Caenorhabditis elegans. G3 (Bethesda) (2014) 0.81
Cell architecture: surrounding muscle cells shape gland cell morphology in the Caenorhabditis elegans pharynx. Genetics (2011) 0.81
Combinatorial roles of heparan sulfate proteoglycans and heparan sulfates in Caenorhabditis elegans neural development. PLoS One (2014) 0.81
Comparative characterisation of recombinant invertebrate and vertebrate peptide O-Xylosyltransferases. Glycoconj J (2006) 0.80
The nematode Caenorhabditis elegans as a model to study the roles of proteoglycans. Glycoconj J (2003) 0.79
Evolution of the perlecan/HSPG2 gene and its activation in regenerating Nematostella vectensis. PLoS One (2015) 0.78
Role of the extracellular matrix in epithelial morphogenesis: a view from C. elegans. Organogenesis (2012) 0.77
Functional Requirements for Heparan Sulfate Biosynthesis in Morphogenesis and Nervous System Development in C. elegans. PLoS Genet (2017) 0.77
Twitchin kinase interacts with MAPKAP kinase 2 in Caenorhabditis elegans striated muscle. Mol Biol Cell (2015) 0.77
Mechanisms of FGF gradient formation during embryogenesis. Semin Cell Dev Biol (2015) 0.77
Basement Membranes in the Worm: A Dynamic Scaffolding that Instructs Cellular Behaviors and Shapes Tissues. Curr Top Membr (2015) 0.76
The Genetics of Axon Guidance and Axon Regeneration in Caenorhabditis elegans. Genetics (2016) 0.76
The Caenorhabditis elegans Ephrin EFN-4 Functions Non-cell Autonomously with Heparan Sulfate Proteoglycans to Promote Axon Outgrowth and Branching. Genetics (2015) 0.76
A novel mutation in β integrin reveals an integrin-mediated interaction between the extracellular matrix and cki-1/p27KIP1. PLoS One (2012) 0.75
Sequence of an unusually large protein implicated in regulation of myosin activity in C. elegans. Nature (1989) 3.49
Gene expression profiling of cells, tissues, and developmental stages of the nematode C. elegans. Cold Spring Harb Symp Quant Biol (2003) 3.22
Comparative clinical study of protein SAP (amyloid P component) and C-reactive protein in serum. Clin Exp Immunol (1978) 3.06
Increased rates of muscle protein turnover and amino acid transport after resistance exercise in humans. Am J Physiol (1995) 2.78
Structural basis for the topological specificity function of MinE. Nat Struct Biol (2000) 2.62
Molecular cloning of the muscle gene unc-22 in Caenorhabditis elegans by Tc1 transposon tagging. Proc Natl Acad Sci U S A (1986) 2.56
Iliopsoas bursitis-an unusual presentation of metastatic bone disease. Br J Rheumatol (1996) 2.32
Sequence analysis of mutations that affect the synthesis, assembly and enzymatic activity of the unc-54 myosin heavy chain of Caenorhabditis elegans. J Mol Biol (1985) 2.29
Assembly of body wall muscle and muscle cell attachment structures in Caenorhabditis elegans. J Cell Biol (1994) 2.26
Spontaneous unstable unc-22 IV mutations in C. elegans var. Bergerac. Genetics (1984) 2.24
Solution structure of the single-strand break repair protein XRCC1 N-terminal domain. Nat Struct Biol (1999) 2.20
A conserved LIM protein that affects muscular adherens junction integrity and mechanosensory function in Caenorhabditis elegans. J Cell Biol (1999) 2.17
Defective reticuloendothelial system function in rheumatoid arthritis. Lancet (1979) 2.10
The UNC-112 gene in Caenorhabditis elegans encodes a novel component of cell-matrix adhesion structures required for integrin localization in the muscle cell membrane. J Cell Biol (2000) 2.06
Minocycline-related lupus. Br J Rheumatol (1994) 1.96
Analysis of a mutator activity necessary for germline transposition and excision of Tc1 transposable elements in Caenorhabditis elegans. Genetics (1988) 1.90
Immune complexes in Behçet's syndrome and recurrent oral ulceration. Br Med J (1977) 1.88
Production of antisense RNA leads to effective and specific inhibition of gene expression in C. elegans muscle. Development (1991) 1.86
Mutations in the unc-54 myosin heavy chain gene of Caenorhabditis elegans that alter contractility but not muscle structure. Cell (1982) 1.83
Molecular cloning and expression of flagellar radial spoke and dynein genes of Chlamydomonas. J Cell Biol (1986) 1.83
Behçet's syndrome: severe proctitis with rectovaginal fistula formation. Ann Rheum Dis (1989) 1.61
Rescue of a paralyzed-flagella mutant of Chlamydomonas by transformation. Proc Natl Acad Sci U S A (1990) 1.60
Circulating immune complexes and symptoms in Hodgkin's disease. Lancet (1976) 1.53
Idiopathic recurrent non-suppurative focal myositis: a report of two cases. Br J Rheumatol (1993) 1.49
Glucose kinetics during high-intensity exercise in endurance-trained and untrained humans. J Appl Physiol (1985) (1995) 1.48
NMR docking of a substrate into the X-ray structure of staphylococcal nuclease. Proteins (1992) 1.46
Transposable element Tc1 of Caenorhabditis elegans recognizes specific target sequences for integration. Proc Natl Acad Sci U S A (1988) 1.44
Insulin action on muscle protein kinetics and amino acid transport during recovery after resistance exercise. Diabetes (1999) 1.44
Formaldehyde mutagenesis in the nematode Caenorhabditis elegans. Mutat Res (1981) 1.43
Transposon-induced deletions in unc-22 of C. elegans associated with almost normal gene activity. Nature (1988) 1.40
Essential genes and deficiencies in the unc-22 IV region of Caenorhabditis elegans. Genetics (1982) 1.39
The dimerization and topological specificity functions of MinE reside in a structurally autonomous C-terminal domain. Mol Microbiol (1999) 1.36
Solution structure of a viral DNA repair polymerase. Nat Struct Biol (2001) 1.36
Functional analysis of the amino-terminal 8-kDa domain of DNA polymerase beta as revealed by site-directed mutagenesis. DNA binding and 5'-deoxyribose phosphate lyase activities. J Biol Chem (1998) 1.35
Mutations in the unc-52 gene responsible for body wall muscle defects in adult Caenorhabditis elegans are located in alternatively spliced exons. Genetics (1995) 1.35
Domain specific interaction in the XRCC1-DNA polymerase beta complex. Nucleic Acids Res (2000) 1.34
Genetic fine structure analysis of the myosin heavy chain gene unc-54 of Caenorhabditis elegans. J Mol Biol (1982) 1.33
Sequence analysis reveals homology between two proteins of the flagellar radial spoke. Mol Cell Biol (1992) 1.32
Solution structure of a dynein motor domain associated light chain. Nat Struct Biol (2000) 1.23
Disease activity in the nephritis of systemic lupus erythematosus in relation to serum complement concentrations. DNA-binding capacity and precipitating anti-DNA antibody. Clin Exp Immunol (1976) 1.22
Measurement of terminal complement complexes in rheumatoid arthritis. Clin Exp Immunol (1988) 1.20
The mec-8 gene of C. elegans encodes a protein with two RNA recognition motifs and regulates alternative splicing of unc-52 transcripts. Development (1996) 1.19
Complex patterns of alternative splicing mediate the spatial and temporal distribution of perlecan/UNC-52 in Caenorhabditis elegans. Mol Biol Cell (1999) 1.13
Cushing's syndrome with suppression of the hypothalamic-pituitary-adrenal axis after intra-articular steroid injections. Ann Rheum Dis (1985) 1.12
Backbone dynamics and refined solution structure of the N-terminal domain of DNA polymerase beta. Correlation with DNA binding and dRP lyase activity. J Mol Biol (2000) 1.12
Stimulation of human rheumatoid synovial cells by non-lethal complement membrane attack. Immunology (1990) 1.12
Correlation between immune complexes and prognostic factors in Hodgkin's disease. Clin Exp Immunol (1978) 1.11
Cell autonomous expression of perlecan and plasticity of cell shape in embryonic muscle of Caenorhabditis elegans. Dev Biol (1996) 1.09
Interstrain crosses enhance excision of Tc1 transposable elements in Caenorhabditis elegans. Mol Gen Genet (1990) 1.09
Mapping of the 5'-2-deoxyribose-5-phosphate lyase active site in DNA polymerase beta by mass spectrometry. J Biol Chem (2000) 1.07
Liposomal clodronate eliminates synovial macrophages, reduces inflammation and ameliorates joint destruction in antigen-induced arthritis. Rheumatology (Oxford) (1999) 1.06
Muscle protein metabolism in female swimmers after a combination of resistance and endurance exercise. J Appl Physiol (1985) (1996) 1.06
Deposition of eosinophil cationic protein in granulomas in allergic granulomatosis and vasculitis: the Churg-Strauss syndrome. Br Med J (Clin Res Ed) (1984) 1.06
Detection of immune complexes in serum of patients with ankylosing spondylitis. Ann Rheum Dis (1978) 1.05
The let-268 locus of Caenorhabditis elegans encodes a procollagen lysyl hydroxylase that is essential for type IV collagen secretion. Dev Biol (2000) 1.03
In vivo and in vitro evidence of cell recovery from complement attack in rheumatoid synovium. Clin Exp Immunol (1988) 1.02
Genomic organization, expression, and analysis of the troponin C gene pat-10 of Caenorhabditis elegans. J Cell Biol (1999) 1.02
Letter: Precipitating antibodies in systemic lupus. Lancet (1974) 1.01
Calcium pyrophosphate deposition disease--involvement of the acromioclavicular joint with pseudocyst formation. Br J Rheumatol (1993) 1.00
Assignments of 1H, 15N, and 13C resonances for the backbone and side chains of the N-terminal domain of DNA polymerase beta. Determination of the secondary structure and tertiary contacts. Biochemistry (1994) 0.99
Synovial accumulation of technetium labelled liposomes in rheumatoid arthritis. Ann Rheum Dis (1987) 0.98
Improved functional ability in patients with rheumatoid arthritis--longterm treatment with leflunomide versus sulfasalazine. European Leflunomide Study Group. J Rheumatol (2001) 0.98
Therapeutic efficacy of a novel membrane-targeted complement regulator in antigen-induced arthritis in the rat. Arthritis Rheum (2000) 0.97
Stereochemistry of the concerted enolization catalyzed by delta 5-3-ketosteroid isomerase. Biochemistry (1991) 0.97
Mutations in the sup-38 gene of Caenorhabditis elegans suppress muscle-attachment defects in unc-52 mutants. Genetics (1992) 0.97
Expression of complement regulatory molecules and other surface markers on neutrophils from synovial fluid and blood of patients with rheumatoid arthritis. Br J Rheumatol (1994) 0.96
Secondary and tertiary structural changes in gamma delta resolvase: comparison of the wild-type enzyme, the I110R mutant, and the C-terminal DNA binding domain in solution. Protein Sci (1997) 0.96
Tumour necrosis factor activity in joint fluids from rheumatoid arthritis patients. Br J Rheumatol (1989) 0.95
Anti-C1q column: ligand specific purification of immune complexes from human serum or plasma. Analysis of the interaction between C1q and immune complexes. Clin Exp Immunol (1982) 0.94
Synthesis and characterization of 5-[(4-Azidophenacyl)thio]uridine 5'-triphosphate, a cleavable photo-cross-linking nucleotide analogue. Biochemistry (1989) 0.94
Studies in the rat of antibody-coated and N-ethylmaleimide-treated erythrocyte clearance by the spleen. I. Effects of in vivo complement activation. Immunology (1986) 0.94
Minocycline-induced lupus: clinical features and response to rechallenge. Rheumatology (Oxford) (2001) 0.93
Local therapy with soluble complement receptor 1 (sCR1) suppresses inflammation in rat mono-articular arthritis. Clin Exp Immunol (1997) 0.93
UNC-52/perlecan isoform diversity and function in Caenorhabditis elegans. Biochem Soc Trans (2001) 0.92
Small-intestinal perforation secondary to localized giant-cell arteritis of the mesenteric vessels. Br J Rheumatol (1988) 0.92
Antiribosomal P protein antibodies in different populations of patients with systemic lupus erythematosus. Br J Rheumatol (1993) 0.92
Inflammatory joint disease: a comparison of liposome scanning, bone scanning, and radiography. Ann Rheum Dis (1988) 0.90
Antibodies to protein P in systemic lupus erythematosus. Ann Rheum Dis (1992) 0.90
Studies in the rat of antibody-sensitized and N-ethylmaleimide-treated erythrocyte clearance by the liver: effects of immune complex infusion and complement activation. Immunology (1988) 0.89
Amelioration of rat antigen-induced arthritis by liposomally conjugated methotrexate is accompanied by down-regulation of cytokine mRNA expression. Rheumatology (Oxford) (2001) 0.89
A single intra-articular injection of liposomally conjugated methotrexate suppresses joint inflammation in rat antigen-induced arthritis. Br J Rheumatol (1996) 0.88
Conformation of an enzyme-bound substrate of staphylococcal nuclease as determined by NMR. Biochemistry (1991) 0.88
Determination of the structure of the DNA binding domain of gamma delta resolvase in solution. Protein Sci (1994) 0.88
The penetration of ceftriaxone into synovial fluid of the inflamed joint. J Antimicrob Chemother (1985) 0.87
Circulating immune complexes in patients with ankylosing spondylitis. Ann Rheum Dis (1980) 0.87
Studies in cobra venom factor treated rats of antibody coated erythrocyte clearance by the spleen: differential influence of red blood cell antigen number on the inhibitory effects of immune complexes on Fc dependent clearance. Clin Exp Immunol (1986) 0.87
Suppression of chronic streptococcal cell wall-induced arthritis in Lewis rats by liposomal clodronate. Rheumatology (Oxford) (2001) 0.87
The effect of liposomally conjugated methotrexate upon mediator release from human peripheral blood monocytes. Br J Rheumatol (1995) 0.86
Systemic lupus erythematosus presenting as pneumococcal septicaemia and septic arthritis. Ann Rheum Dis (1990) 0.86
Imaging in rheumatoid arthritis using liposomes labelled with technetium. Br Med J (Clin Res Ed) (1986) 0.86
Three-dimensional solution structure of the N-terminal domain of DNA polymerase beta and mapping of the ssDNA interaction interface. Biochemistry (1996) 0.86
Interaction of the bHLH-zip domain of c-Myc with H1-type peptides. Characterization of helicity in the H1 peptides by NMR. J Biol Chem (1994) 0.86
Studies of the dimerization and domain structure of gamma delta resolvase. J Biol Chem (1993) 0.85
Oral branched-chain amino acids decrease whole-body proteolysis. JPEN J Parenter Enteral Nutr (1995) 0.85